Tumor Necrosis Factor-α Is a Potent Endogenous Mutagen that Promotes Cellular Transformation
Open Access
- 15 December 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (24) , 11565-11570
- https://doi.org/10.1158/0008-5472.can-06-2540
Abstract
Tumor necrosis factor-α (TNF-α) is an important inflammation cytokine without known direct effect on DNA. In this study, we found that TNF-α can cause DNA damages through reactive oxygen species. The mutagenic effect of TNF-α is comparable with that of ionizing radiation. TNF-α treatment in cultured cells resulted in increased gene mutations, gene amplification, micronuclei formation, and chromosomal instability. Antioxidants significantly reduced TNF-α–induced genetic damage. TNF-α also induced oxidative stress and nucleotide damages in mouse tissues in vivo. Moreover, TNF-α treatment alone led to increased malignant transformation of mouse embryo fibroblasts, which could be partially suppressed by antioxidants. As TNF-α is involved in chronic inflammatory diseases, such as chronic hepatitis, ulcerative colitis, and chronic skin ulcers, and these diseases predispose the patients to cancer development, our results suggest a novel pathway through which TNF-α promotes cancer development through induction of gene mutations, in addition to the previously reported mechanisms, in which nuclear factor-κB activation was implicated. (Cancer Res 2006; 66(24): 11565-70)Keywords
All Related Versions
This publication has 19 references indexed in Scilit:
- Apoptotic DNA fragmentation factor maintains chromosome stability in a P53-independent mannerOncogene, 2006
- An inflammatory linkNature, 2004
- Regulation of Fas (CD95)-induced apoptotic and necrotic cell death by reactive oxygen species in macrophagesJournal of Cellular Physiology, 2004
- Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regressionCancer Cell, 2004
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- Role of the Intronic Enhancer in Tumor Necrosis Factor-mediated Induction of Manganous Superoxide DismutaseJournal of Biological Chemistry, 2003
- Inflammation and cancerNature, 2002
- Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathwayOncogene, 2002
- Tumor Necrosis Factor-α Increases the Steady-state Reduction of Cytochrome b of the Mitochondrial Respiratory Chain in Metabolically Inhibited L929 CellsJournal of Biological Chemistry, 2000
- Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.Proceedings of the National Academy of Sciences, 1989